Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA appoints Isabel De Paoli as communications head

She will replace Walter Huber, who retires inMarch 2016

Merck KGaA Isabel De PaoliMerck KGaA has picked a new head of group communications to take over from Walter Huber, who is set to retire next March after 18 years in the role.

Isabel De Paoli (pictured) is currently head of group strategy at the German life sciences, health and materials company and will officially step into her new role when Huber's tenure ends.

Until then she will spend her time preparing for her new role and Heiko Schön has taken over from her as head of group strategy at Merck.

In her new role, De Paoli will be responsible for all global communications at Merck.

Karl-Ludwig Kley, chairman of Merck's executive board, said: “Isabel De Paoli brings many years of experience in shaping and implementing strategic topics as well as an international background - capabilities that are becoming ever more important in a rapidly changing communications environment.”

De Paoli joined Merck in August 2006 as business development manager, chemicals, was appointed head of strategic planning oncology in 2009 and in 2012 took on responsibility for group strategy.

Prior to joining Merck she began her career as a consultant, working for The Boston Consulting Group and then moving to private equity firm Permira.

11th August 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics